Inflammation/Immunology
-
Inflammation/Immunology Related Products (20898)
Related Products (20898)
-
Antibodies (115)
-
Related Compound Screening Libraries (4)
-
Bronchospasmolytic agent 1
0 ImagesCat. No.: HY-U00405CAS No.: 63516-10-9Bronchospasmolytic agent 1, a synthetic flutropium bromide compound, acts as a bronchospasmolytic agent.
-
SR121566A
0 ImagesCat. No.: HY-U00235CAS No.: 180144-61-0SR121566A is a novel non-peptide Glycoprotein IIb/IIIa (GP IIb-IIIa) antagonist, which can inhibit ADP-, arachidonic acid- and collagen-induced human platelet aggregation with IC50s of 46±7.5, 56±6 and 42±3 nM, respectively.
-
COX/5-LO-IN-1
0 ImagesCat. No.: HY-U00347CAS No.: 154355-75-6Synonyms: Atreleuton analogCOX/5-LO-IN-1 (Atreleuton analog) is an inhibitor of cylooxygenase and 5-lipoxygenase (5-LO), used for the research of inflammatory and allergic disease states.
-
S3337
0 ImagesCat. No.: HY-U00222CAS No.: 108499-48-5S3337 is an H+, K+-ATPase inhibitor.
-
CI-949
0 ImagesCat. No.: HY-U00364CAS No.: 104961-19-5CI-949 is an allergic mediator release inhibitor, which inhibits histamine, leukotriene C4/D4 (LTC4/LTD4), and thromboxane B2 (TXB2) release with IC50s of 11.4 μM, 0.5 μM and 0.1 μM, respectively.
-
Antiasthmatic Compound 1
0 ImagesCat. No.: HY-U00409CAS No.: 63768-49-0Antiasthmatic Compound 1 is an antiasthmatic agent, which has the potential for allergic asthma treatment.
-
TRPV antagonist 1
0 ImagesCat. No.: HY-U00330CAS No.: 1192871-27-4TRPV antagonist 1 is a transient receptor potential vanilloid (TRPV) antagonist, with an IC50 of < 250 nM.
-
PDE IV-IN-1
0 ImagesCat. No.: HY-U00352CAS No.: 225100-12-9PDE IV-IN-1 is an inhibitor of phosphodiesterase IV, used for the research of asthma, COPD or other inflammatory diseases.
-
L-689502
0 ImagesCat. No.: HY-U00261CAS No.: 138483-63-3L-689502 is a potent inhibitor of HIV-l protease with an IC50 of 1 nM.
-
CB1 antagonist 1
0 ImagesCat. No.: HY-U00397CAS No.: 890037-68-0CB1 antagonist 1 is an antagonist of CB1 receptor, used in the research of metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, gastrointestinal disorders, and cardiovascular conditions.
-
A2B receptor antagonist 1
0 ImagesCat. No.: HY-U00321CAS No.: 531506-36-2A2B receptor antagonist 1 is a potent A2B adenosine receptor antagonist extracted from patent WO 2009157938 A1 EXAMPLE 9B.
-
FRG8701
0 ImagesCat. No.: HY-U00238CAS No.: 108498-50-6FRG-8701 is a new Histamine H2-receptor antagonist with an IC50 of ranging from 0.25 to 0.43 μM.
-
Deloxolone
0 ImagesCat. No.: HY-U00278CAS No.: 68635-50-7Synonyms: (3β,20β)-3-(3-Carboxy-1-oxopropoxy)olean-9(11)-en-29-oic acidDeloxolone has the potential for inflammatory, ischemic and proliferative diseases treatment.
-
Chymase-IN-2
0 ImagesCat. No.: HY-U00282CAS No.: 936366-22-2Chymase-IN-2 is a chymase modulator which is useful in the treatment of inflammatory and serine protease mediated disorders.
-
UP202-56
0 ImagesCat. No.: HY-U00226CAS No.: 163838-04-8UP202-56 is an adenosine analogue, which is an adenosinergic agonist.
-
Tuftsin diacetate
0 ImagesCat. No.: HY-P0240ACAS No.: 72103-53-8Tuftsin diacetate, a tetrapeptide, is a macrophage/microglial activator.
-
Anti-inflammatory agent 1
0 ImagesCat. No.: HY-U00273CAS No.: 1096621-42-9Anti-inflammatory agent 1 is an anti-inflammatory agent extracted from patent WO 2009003229 A1, example 36.
